Environmental modeling and toxicology project outlines vehicle emission profiles and secondary particulate matter formation across urban regions, highlighting widespread health and policy impacts.
PAREMPI PARTICLE EMISSION PREVENTION AND IMPACT: FROM REAL-WORLD EMISSIONS OF TRAFFIC TO SECONDARY PM OF URBAN AIR Public Deliverables Public Deliverables No Title Lead D2.2 Measurement results of emissions, secondary aerosol forming potential and methodology TAU D2.3 Evaluation of robust measurement methods for estimating secondary aerosol mass VTT D3.1 Aerosol dynamics during exhaust dilution and cooling ULUND D3.2 Secondary aerosol formation from representative (S)VOCs TAU D3.3 European and global scale estimates of the vehicle fleet contribution to organic and inorganic PM2.5 and nano-particle concentrations during all seasons ULUND D3.4 Digital equivalent total particles emissions index (ePMI) module software ULUND D4.1 Health impact assessment and societal costs (HIA) ULUND D4.2 Toxicity results for exhaust and secondary aerosols using basal and easily measured of toxicity markers and advanced microscopic methods IEM D4.3 Literature review and toxicity rating of exhaust and secondary aerosols IEM D5.1 Database of emissions, secondary aerosols and toxicity rating, Excel file FMI D5.2 Summary report of precursor emissions, secondary aerosol forming potential and toxicity BOSMAL D5.3 Scientific summary report FMI D5.4 Policy recommendations report VTT
No takes yet. Share an insight, caveat, or question.
Finland et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: